Turning Point Therapeutics, Inc.
TPTXDelisted Aug 17, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595893
Turning Point Therapeutics, Inc. was delisted on Aug 17, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 209 institutions reported holding it in 13F filings for Q2 2022, worth $3.29B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Turning Point Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 172 | 2 | 154 | −16 |
| Shares | 45.1M | 17.1K | 45.9M | +791.1K (+1.8%) |
| Value | $2.15B | $814.0K | $1.23B | −$914.8M (−42.6%) |
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (25)
Institutions that held Turning Point Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boxer Capital, LLC | 400,000 | $10.7M | 0.55% |
| Brookfield Asset Management Inc. | 77,488 | $2.08M | 0.01% |
| Squarepoint Ops LLC | 53,847 | $1.45M | 0.01% |
| PDT Partners, LLC | 41,760 | $1.12M | 0.10% |
| Jump Financial, LLC | 40,101 | $1.08M | 0.05% |
| Two Sigma Advisers, LP | 23,600 | $634.0K | 0.00% |
| Walleye Capital LLC | 22,556 | $606.0K | 0.02% |
| Trexquant Investment LP | 21,893 | $588.0K | 0.03% |
| HighVista Strategies LLC | 21,037 | $565.0K | 0.36% |
| Renaissance Technologies LLC | 18,700 | $502.0K | 0.00% |
| NinePointTwo Capital | 18,375 | $493.0K | 0.13% |
| Engineers Gate Manager LP | 14,650 | $393.0K | 0.02% |
| IndexIQ Advisors LLC | 14,134 | $379.0K | 0.01% |
| Twinbeech Capital LP | 10,820 | $291.0K | 0.01% |
| Quantbot Technologies LP | 9,947 | $267.0K | 0.02% |
| Qube Research & Technologies Ltd | 9,060 | $243.0K | 0.00% |
| Virtu Financial LLC | 8,834 | $237.0K | 0.02% |
| Amalgamated Financial Corp. | 5,765 | $155.0K | 0.00% |
| Amundi | 3,682 | $98.0K | 0.00% |
| Point72 Hong Kong Ltd | 3,559 | $96.0K | 0.01% |
| Ellevest, Inc. | 25 | $1.00K | 0.00% |
| TCWP LLC | 38 | $1.00K | 0.00% |
| Disciplined Investments, LLC | 2 | $0 | 0.00% |
| Cordant, Inc. | 2 | $0 | 0.00% |
| Schubert & Co | 2 | $0 | 0.00% |
Sold out (41)
Institutions that held Turning Point Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
Not filed for Q1 2022 yet (2)
Institutions that held Turning Point Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| AlphaCentric Advisors LLC | 17,000 | $811.0K |
| Bell Investment Advisors, Inc | 72 | $3.00K |